Y-Intercept (HK)’s iTeos Therapeutics ITOS Stock Holding History

Y-Intercept (HK)’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-28,375	Closed	-$283K	–	1793
2025 Q2	$283K	Buy	28,375 +10,251	+57%	+$82.6K	0.01%	1376
2025 Q1	$108K	Sell	18,124 -344	-2%	-$2.53K	0.01%	1111
2024 Q4	$142K	Buy	+18,468	New	+$159K	0.01%	1082
2024 Q3	–	Sell	-20,814	Closed	-$309K	–	1553
2024 Q2	$309K	Buy	+20,814	New	+$298K	0.02%	1028
2024 Q1	–	Sell	-26,430	Closed	-$289K	–	1562
2023 Q4	$289K	Sell	26,430 -5	-0%	-$50	0.03%	841
2023 Q3	$289K	Buy	+26,435	New	+$338K	0.03%	789
2023 Q2	–	Sell	-13,573	Closed	-$185K	–	1490
2023 Q1	$185K	Buy	13,573 +534	+4%	+$9.57K	0.02%	984
2022 Q4	$255K	Buy	+13,039	New	+$255K	0.04%	731

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Y-Intercept (HK)'s ITOS Position: Q3 2025 in Review

Y-Intercept (HK) sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 28,375 shares — an estimated $283K sold.

Y-Intercept (HK) first reported a position in ITOS in Q4 2022 and held it in 8 quarters. The position peaked at $309K in Q2 2024. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

Y-Intercept (HK) reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
Y-Intercept (HK) sold 28,375 iTeos Therapeutics shares in Q3 2025, an estimated $283K.
Y-Intercept (HK) first reported a position in iTeos Therapeutics in Q4 2022 and held it in 8 quarters.
Y-Intercept (HK)'s iTeos Therapeutics position peaked at $309K in Q2 2024.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Y-Intercept (HK)'s 13F filing for Q3 2025, filed 31 Oct 2025.